CIL | VXUS | CIL / VXUS | |
Gain YTD | 11.079 | 6.198 | 179% |
Net Assets | 104M | 455B | 0% |
Total Expense Ratio | 0.45 | 0.05 | 900% |
Turnover | 30.00 | 3.00 | 1,000% |
Yield | 3.17 | 3.15 | 101% |
Fund Existence | 10 years | 14 years | - |
VXUS | |
---|---|
RSI ODDS (%) | 2 days ago90% |
Stochastic ODDS (%) | 2 days ago72% |
Momentum ODDS (%) | 2 days ago85% |
MACD ODDS (%) | 2 days ago89% |
TrendWeek ODDS (%) | 2 days ago80% |
TrendMonth ODDS (%) | 2 days ago77% |
Advances ODDS (%) | 2 days ago80% |
Declines ODDS (%) | 17 days ago78% |
BollingerBands ODDS (%) | 2 days ago85% |
Aroon ODDS (%) | 2 days ago76% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
DTEC | 42.33 | 0.71 | +1.70% |
ALPS Disruptive Technologies ETF | |||
HNDL | 20.18 | 0.17 | +0.85% |
Strategy Shares Nasdaq 7 Handl™ ETF | |||
FTXH | 24.63 | 0.08 | +0.33% |
First Trust Nasdaq Pharmaceuticals ETF | |||
IDV | 31.63 | -0.06 | -0.19% |
iShares International Select Div ETF | |||
PIN | 25.77 | -0.19 | -0.73% |
Invesco India ETF |